Forever Young: The Protandim Surge (Part 2)
Some observers of the anti-aging movement express skepticism about Protandim and its boosters' claims. Apparently this is due to two things, mainly:
1) The belief that nutritional supplementation is a dead-end path to significant extension of human lifespans.
2) The suspicion that the company promoting Protandim is trying to pull a bait-and-switch on the public. To understand some of the history of Protandim and the skeptics' argument on this point, I turn to the Fight Aging web site and the post by the commentator called "Reason," who seems to have as good a handle on the controversy as anyone. Reason writes that, "The short version can be told as follows" (the bulleted statements are his):
As for the supposed problem with nutritional supplements vis-a-via life extension, read the commentary on the official Mprize (Methuselah Mouse) site, called "Cashing in on Protandim" as well as this post on the Longevity First web site (where I learned about something called the Gompertz Law for the first time).
All very interesting.
And yet ... I still want a magic pill as a key part of my anti-aging regime! I'll be watching the coming fortunes of Protandim with interest-- and by that I mean not just the financial fortunes of the Lifeline company, but the life-extension gains of the people who decide to take it. (But how will those gains be measured, I wonder, except by waiting a long, long time?)
Technorati Tags:
Protandim, supplements, nutrition, anti-aging, antiaging, longevity, life extension, aging, gerontology, science, antioxidants, venture capitalism, venture funding, business, Methuseleh Mouse, research, skepticism
1) The belief that nutritional supplementation is a dead-end path to significant extension of human lifespans.
2) The suspicion that the company promoting Protandim is trying to pull a bait-and-switch on the public. To understand some of the history of Protandim and the skeptics' argument on this point, I turn to the Fight Aging web site and the post by the commentator called "Reason," who seems to have as good a handle on the controversy as anyone. Reason writes that, "The short version can be told as follows" (the bulleted statements are his):
(I've condensed Reason's remarks above somewhat; I recommend reading the full post at Fight Aging.)
- CereMedix tests a compound that could extend life span by mitigating oxidative stress. This is CMX-1152 ... .
- Lifeline is founded on the basis of a licensing deal with CereMedix; the Protandim name is later assigned to CMX-1152
- Around this time, I begin to comment on this deal, CMX-1152, Protandim and Lifeline. ...
- For reasons that remain unclear, Lifeline does not proceed with CMX-1152, but rather begins looking for a new product to market under the existing brand name of Protandim.
- For a time, Lifeline continues to use the experimental results from CMX-1152 to tout their new non-CMX-1152 product, which could charitably be described as a potpourri of existing antioxidant supplements. ... Not cricket, gentlemen.
- Now we see a more mature offering from Lifeline, at least in the marketing department. They have retained the focus on oxidative stress, but are building a brand on the work of different scientists.
- So far as it goes, it looks like Lifeline is still selling the potpourri of existing supplements.
As for the supposed problem with nutritional supplements vis-a-via life extension, read the commentary on the official Mprize (Methuselah Mouse) site, called "Cashing in on Protandim" as well as this post on the Longevity First web site (where I learned about something called the Gompertz Law for the first time).
All very interesting.
And yet ... I still want a magic pill as a key part of my anti-aging regime! I'll be watching the coming fortunes of Protandim with interest-- and by that I mean not just the financial fortunes of the Lifeline company, but the life-extension gains of the people who decide to take it. (But how will those gains be measured, I wonder, except by waiting a long, long time?)
Technorati Tags:
Protandim, supplements, nutrition, anti-aging, antiaging, longevity, life extension, aging, gerontology, science, antioxidants, venture capitalism, venture funding, business, Methuseleh Mouse, research, skepticism






3 Comments:
Good posting on protandim there! It will be important for us in the life extension community to be wary of various characters defaming the cause.
I wanted to bring everyone's attention to the controversy brewing over MIT Tech Review's challenge to the MPrize. Here they want to give Dr. de Grey's SENS proposal a proper hearing. So far they had invited Dr. Cynthia Kenyon, another leading light in the anti-aging community, but alas she declined, citing that she was unable to offer a proper critique. For the link, go here:
http://pontin.trblogs.com/archives/2005/05/cynthia_kenyon_1.html
Note that the Methuselah Foundation is offering a $5000US honorarium to help defray the expenses for the biogerontologist that Technology Review selects.
Michael: Thanks for this information. I hope someone will take up this offer.
It turns out that Protandim works as advertised after all. All the negative comments were wrong. Protandim's peer review human study is now published.
New Scientific Data Demonstrate Protandim(R) Improves the Body's Natural Ability to Reduce Oxidative Stress by Increasing Activity of Antioxidant Enzymes
DENVER, Jan. 17 /PRNewswire-FirstCall/ -- Lifeline Therapeutics, Inc. (OTC Bulletin Board: LFLT - News) announced data from a human study just published in the scientific journal, Free Radical Biology & Medicine (Jan. 15, 2006), demonstrated Protandim® was able to reduce oxidative stress in men and women.
In this study, before starting Protandim®, study participants, who ranged in age from 20 to 78, showed a strong age-related increase in TBARS. After 30 days of taking Protandim®, a 40 percent average decrease in TBARS was seen, and the age-related increase was eliminated. By 120 days of supplementation, Protandim® also significantly increased activity of SOD and CAT antioxidant enzymes by 30 percent and 54 percent, respectively.
No other antioxidant can prove this claim. Here is a link to the news release.
http://biz.yahoo.com/prnews/060117/cgtu054.html?.v=38
Protandim's new scientific study can be viewed in its entirety at,
http://www.protandim.com/pdf/Protandim%20FRBM%202006.pdf
The induction of human superoxide dismutase and catalase in vivo:A fundamentally new approach to antioxidant therapy
Happy reading
Post a Comment
Links to this post:
Create a Link
<< Home